SAN FRANCISCO, June 07, 2023 (Globe NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today declared that 5 abstracts highlighting new...
Abstracts
Late-breaking poster presentation to highlight preclinical data demonstrating that the increased potency of CD8-targeted fusosomes enhances CAR gene delivery to...